Sentien Biotechnologies
PrivateLast Round
Grant
Sep 20, 2021
Total Funding Raised
$15.05M
Company Overview
Sentien Biotechnologies operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. Its latest recorded funding round was a Grant round in September 2021.
Sentien Biotechnologies is a clinical-stage biotechnology company developing novel approaches to cell therapy for patients with systemic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentien Biotechnologies Comparables
Compare Sentien Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeaStar Medical Holding Corporation | 83% | |
| Baxter International Inc | 73% | |
| Hemotune AG | 73% |
For institutional investors. Book with your work email.
Sentien Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 20, 2021 | ||||
| Series A | Apr 4, 2017 | ||||
| Seed | Aug 7, 2015 |
For institutional investors. Book with your work email.
Sentien Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioInnovation Capital | Series A |
| Chiesi Ventures | Series A |
| Boehringer Ingelheim Venture Fund | Seed, Series A |
| Maryland Stem Cell Research Fund | Grant |
| MBL Venture Capital | Series A |
| Mass Medical Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2021
$535K grant from Maryland Stem Cell Research Fund.
For institutional investors. Book with your work email.
Sentien Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sentien Biotechnologies's valuation, stock price, and market status.
Is Sentien Biotechnologies a public or private company?
Sentien Biotechnologies is a private company.
What is the current stock price of Sentien Biotechnologies?
Sentien Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Sentien Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sentien Biotechnologies worth (valuation)?
Valuation information for Sentien Biotechnologies is not publicly available.
Can I buy Sentien Biotechnologies stock?
Sentien Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sentien Biotechnologies's last funding round?
Sentien Biotechnologies's most recent funding round was Grant on September 20, 2021.
Who are the main investors in Sentien Biotechnologies?
Key investors in Sentien Biotechnologies include BioInnovation Capital, Boehringer Ingelheim Venture Fund.
Will Sentien Biotechnologies IPO soon?
No public IPO plans have been announced for Sentien Biotechnologies.
How can I track Sentien Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Sentien Biotechnologies's shares on secondary markets.